Skip to main content
SpringerLink
Log in

Colloidal Carrier Systems for Transscleral Drug Delivery

  • Chapter
  • First Online:
Drug Delivery for the Retina and Posterior Segment Disease

  • 691 Accesses

Abstract

This chapter aims to describe colloidal carrier systems for transscleral drug delivery as a possible treatment approach for posterior segment ocular diseases. Complexities of eye anatomy pose several difficulties in the treatment of posterior segment ocular diseases. The transscleral route of drug delivery has demonstrated an alternative method to the already widely accepted topical, oral, and intraocular routes for drug administration into retinal segment of the eye. By combining this route of administration with a colloidal carrier system, the active pharmaceutical ingredient shows a higher potential of reaching its target location at a higher concentration while simultaneously mounting patient compliance.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abdelkader H, Ismail S, Kamal A, et al. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization. Pharmazie. 2010;65(11):811–7.

    CAS  PubMed  Google Scholar 

  2. Ali J, Fazil M, Qumbar M, et al. Colloidal drug delivery system: amplify the ocular delivery. Drug Deliv. 2016;23(3):710–26.

    PubMed  Google Scholar 

  3. Ali M, Byrne ME. Challenges and solutions in topical ocular drug-delivery systems. Expert Rev Clin Pharmacol. 2008;1(1):145–61.

    Article  CAS  PubMed  Google Scholar 

  4. Aliautdin RN, Iezhitsa IN, Agarval R. Transcorneal drug delivery: prospects for the use of liposomes. Vestn oftalmol. 2014;130(4):117–22.

    CAS  PubMed  Google Scholar 

  5. Ambati J, Canakis CS, Miller JW, et al. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci. 2000;41(5):1181–5.

    CAS  PubMed  Google Scholar 

  6. Ambati J, Gragoudas ES, Miller JW, et al. Transscleral delivery of bioactive protein to the choroid and retina. Invest Ophthalmol Vis Sci. 2000a;41:1186–91.

    CAS  PubMed  Google Scholar 

  7. Augustin AJ, D’Amico DJ, Mieler WF, et al. Safety of posterior juxtascleral depot administration of the angiostatic cortisene anecortave acetate for treatment of subfoveal choroidal neovascularization in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2005;243(1):9–12.

    Article  CAS  PubMed  Google Scholar 

  8. Carrasquillo KG, Ricker JA, Rigas IK, et al. Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres. Invest Ophthalmol Vis Sci. 2003;44(1):290–9.

    Article  PubMed  Google Scholar 

  9. Chen MS, Hou PK, Tai TY, et al. Blood ocular barriers. Tzu Chi Med J. 2008;20(1):25–34.

    Article  Google Scholar 

  10. Civiale C, Licciardi M, Cavallaro G, et al. Polyhydroxyethyl aspartamide-based micelles for ocular drug delivery. Int J Pharm. 2009;378(1–2):177–86.

    Article  CAS  PubMed  Google Scholar 

  11. Crampton HL, Simanek EE. Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers. Polym Int. 2007;56:489–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Cruysberg LP, Nuijts RM, Geroski DH, et al. In vitro human scleral permeability of fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein and rhodamine 6G and the use of a coated coil as a new drug delivery system. J Ocul Pharmacol Ther. 2002;18:559–69.

    Article  CAS  PubMed  Google Scholar 

  13. Curtin BJ. Physiopathologic aspects of scleral stress-strain. Trans Am Ophthalmol Soc. 1969;67:417–61.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Davis BM, Normando EM, Guo L, et al. Topical delivery of Avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes. Small. 2014;10(8):1575–84.

    Article  CAS  PubMed  Google Scholar 

  15. Duncan R, Izzo L. Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev. 2005;57(15):2215–37.

    Article  CAS  PubMed  Google Scholar 

  16. Dunlevy JR, Rada JA. Interaction of lumican with aggrecan in the aging human sclera. Invest Ophthalmol Vis Sci. 2004;45:3849–56.

    Article  PubMed  Google Scholar 

  17. Elsaid N, Jackson TL, Gunic M, et al. Positively charged amphiphilic chitosan derivative for the transscleral delivery of rapamycin. Invest Ophthalmol Vis Sci. 2012;53(13):8105–11.

    Article  CAS  PubMed  Google Scholar 

  18. Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye (Lond). 2013;27(7):787–94.

    Google Scholar 

  19. Gillies ER, Frechet JMJ. Dendrimers and dendritic polymers in drug delivery. Drug Discov Today. 2005;10:35–43.

    Article  CAS  PubMed  Google Scholar 

  20. Hironaka K, Inokuchi Y, Tozuka Y, et al. Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye. J Control Release. 2009;136(3):247–53.

    Article  CAS  PubMed  Google Scholar 

  21. Jockovich ME, Moshfeghi AA, Hernandez E, et al. Posterior juxtascleral injection of anecortave acetate: localization in rabbit eyes by magnetic resonance and ecographic imaging. Invest Ophthalmol Vis Sci. 2005;46(13):482.

    Google Scholar 

  22. Kaur IP, Garg A, Singla AK, et al. Vesicular systems in ocular drug delivery: an overview. Int J Pharm. 2004;269(1):1–14.

    Article  CAS  PubMed  Google Scholar 

  23. Lu Y, Zhou N, Huang X, et al. Effect of intravitreal injection of bevacizumab-chitosan nanoparticles on retina of diabetic rats. Int J Ophthalmol. 2014;7(1):1–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Luo D, Zhu B, Zheng Z, et al. Subtenon vs Intravitreal triamcinolone injection in diabetic macular edema, a prospective study in Chinese population. Pak J Med Sci. 2014;30(4):749–54.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Mandal A, Bisht R, Rupenthal ID, et al. Polymeric micelles for ocular drug delivery: from structural frameworks to recent preclinical studies. J Control Release. 2017;248:96–116.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Maurice DM, Polgar J. Diffusion across the sclera. Exp Eye Res. 1977;25:577–82.

    Article  CAS  PubMed  Google Scholar 

  27. Mishra GP, Bagui M, Tamboli V, et al. Recent applications of liposomes in ophthalmic drug delivery. J Drug Deliv. 2011;2011:863734. https://doi.org/10.1155/2011/863734.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Myc A, Majoros IJ, Thomas TP, et al. Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells. Biomacromolecules. 2007;8:13–8.

    Article  CAS  PubMed  Google Scholar 

  29. Myles ME, Neumann DM, Hill JM. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis. Adv Drug Deliv Rev. 2005;57:2063–79.

    Article  CAS  PubMed  Google Scholar 

  30. Paganelli F, Cardillo JA, Dare AR, et al. Controlled transscleral drug delivery formulations to the eye: establishing new concepts and paradigms in ocular anti-inflammatory therapeutics and antibacterial prophylaxis. Expert Opin Drug Deliv. 2010;7(8):955–65.

    Article  CAS  PubMed  Google Scholar 

  31. Patel A, Cholkar K, Agrahari V, et al. Ocular drug delivery systems: an overview. World J Pharmacol. 2013;2(2):47–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Prosperi-Porta G, Kedzior S, Muirhead B, et al. Phenylboronic-acid-based polymeric micelles for mucoadhesive anterior segment ocular drug delivery. Biomacromolecules. 2016;17(4):1449–57.

    Article  CAS  PubMed  Google Scholar 

  33. Sahoo R, Biswas N, Guha A, et al. Nonionic surfactant vesicles in ocular delivery: innovative approaches and perspectives. Biomed Res Int. 2014;2014:263604. https://doi.org/10.1155/2014/263604.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Sampat KM, Garg SJ. Complications of intravitreal injections. Curr Opin Ophthalmol. 2010;21(3):178–83.

    Article  PubMed  Google Scholar 

  35. Schultz C, Breaux J, Schentag J, et al. Drug delivery to the posterior segment of the eye through hydrogel contact lenses. Clin Exp Optom. 2011;94(2):212–8.

    Article  PubMed  Google Scholar 

  36. Shah JN, Shah HJ, Groshev A, et al. Nanoparticulate transscleral ocular drug delivery. J Biomol Res Ther. 2014;3:116. https://doi.org/10.4172/2167-7956.1000116.

    Article  CAS  Google Scholar 

  37. Shah SS, Denham LV, Elison JR, et al. Drug delivery to the posterior segment of the eye for pharmacologic therapy. Exp Rev Ophthalmol. 2010;5(1):75–93.

    Article  CAS  Google Scholar 

  38. Srirangam R, Majumdar S. Transscleral drug delivery to the posterior segment of the eye: particulate and colloidal formulations and biopharmaceutical considerations. Advances in Ocular Drug Delivery, Research Signpost. India: Kerala; 2012. p. 33–6.

    Google Scholar 

  39. Tan Ling SK. Study on ocular drug delivery system for treatment of posterior segment eye diseases. 2014. http://hdl.handle.net/10356/55726.

  40. Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998;172:33–70.

    Article  CAS  Google Scholar 

  41. Vaishya RD, Khurana V, Patel S, et al. Controlled ocular drug delivery with nanomicelles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014;6(5):422–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Van Kooij B, Rothova A, De Vries P. The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema. Ocul Immunol Inflamm. 2006;14(2):73–85.

    Article  PubMed  Google Scholar 

  43. Vandamme TF, Brobeck L. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J Control Release. 2005;102(1):23–38.

    Article  CAS  PubMed  Google Scholar 

  44. Viness P, Choonara YE, du Toit LC. Intraocular drug delivery technologies: advancing treatment of posterior segment disorders of the eye. In: Pathak Y, Sutariya V, Hirani A, editors. Nano-biomaterials for ophthalmic drug delivery. Cham: Springer; 2016. p. 413.

    Google Scholar 

  45. Wang XH, Shuang L, Liang L. Evaluation of RPD peptide hydrogel in the posterior segment of the rabbit eye. J Biomater Sci Polym Ed. 2013;24(10):1185–97.

    Article  CAS  PubMed  Google Scholar 

  46. Watson PG, Young RD. Scleral structure, organisation and disease. A review. Exp Eye Res. 2004;78(3):609–23.

    Article  CAS  PubMed  Google Scholar 

  47. Wischke C, Schwendeman SP. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm. 2008;364(2):298–327.

    Article  CAS  PubMed  Google Scholar 

  48. Yavuz B, Pehlivan SB, Vural İ, et al. In Vitro/In Vivo evaluation of dexamethasone-PAMAM dendrimer complexes for retinal drug delivery. J Pharm Sci. 2015;104(11):3814–23.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. ROFEL, Shri G.M. Bilakhia College of Pharmacy, Vapi, Gujarat, India

    Komal Parmar

  2. Nootan Pharmacy College, Faculty of Pharmacy, Sankalchand Patel University, Visnagar, Gujarat, India

    Jayvadan K. Patel

Authors
  1. Komal Parmar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jayvadan K. Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Faculty of Pharmacy, Sankalchand Patel University, Gujarat, India

    Jayvadan K. Patel

  2. College of Pharmacy, University of South Florida, Tampa, FL, USA

    Vijaykumar Sutariya

  3. School of Medicine, Faculty of Health, Deakin University, Victoria, Australia

    Jagat Rakesh Kanwar

  4. College of Pharmacy, University of South Florida, Tampa, FL, USA

    Yashwant V. Pathak

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Parmar, K., Patel, J.K. (2018). Colloidal Carrier Systems for Transscleral Drug Delivery. In: Patel, J., Sutariya, V., Kanwar, J., Pathak, Y. (eds) Drug Delivery for the Retina and Posterior Segment Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-95807-1_13

Download citation

Publish with us

Policies and ethics

Search

Navigation